Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials




Shankar-Hari M, Estcourt L, Harvala H, Roberts D, Menon DK, United Kingdom SARS-CoV-2 Convalescent Plasma Evaluation (SCoPE) Consortium

2020

Critical care (London, England)

24

DOIhttps://doi.org/10.1186/s13054-020-03163-3




Last updated on 2025-27-01 at 19:28